HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): James D. Luketich Michael E. Burt Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luketich, J. D. Articles by Burt, M. E. Search for Related Content PubMed PubMed Citation Articles by Luketich, J. D. Articles by Burt, M. E.

Ann Thorac Surg 1996;62:1614-1616
© 1996 The Society of Thoracic Surgeons

---

Original Articles: General Thoracic

Does Resection of Adrenal Metastases From Non–Small Cell Lung Cancer Improve Survival?

Thoracic Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

Accepted for publication June 26, 1996.

Background. Metastatic non–small cell lung cancer (NSCLC) carries a dismal prognosis, which is minimally affected by chemotherapy. Solitary brain metastases from NSCLC have been resected with 5-year survivals of 10% to 30%. The objective of this study was to determine if resection of isolated adrenal metastases improves survival.

Methods. Isolated adrenal metastases were found in 14 patients with NSCLC. Eight patients had resection after cis-platinum–based chemotherapy, and 6 received chemotherapy alone.

Results. Median survival in the surgical group was significantly greater than that in the chemotherapy group (31 versus 8.5 months; p = 0.03). All patients in the chemotherapy group were dead by 22 months. Three-year actuarial survival in the surgical group was 38%. No difference in locoregional stage, size of adrenal metastases, patient age, or performance status was present between the two groups.

Conclusions. Long-term disease-free survival is possible after resection of isolated adrenal metastases from NSCLC. Resection of isolated adrenal metastases should be considered if the primary NSCLC is resectable.

This article has been cited by other articles:

				T. Tanvetyanon, L. A. Robinson, M. J. Schell, V. E. Strong, R. Kapoor, D. G. Coit, and G. Bepler Outcomes of Adrenalectomy for Isolated Synchronous Versus Metachronous Adrenal Metastases in Non-Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis J. Clin. Oncol., March 1, 2008; 26(7): 1142 - 1147. [Abstract] [Full Text] [PDF]

				F. L. Greene, K. W. Kercher, H. Nelson, C. M. Teigland, and A.-M. Boller Minimal Access Cancer Management CA Cancer J Clin, May 1, 2007; 57(3): 130 - 146. [Abstract] [Full Text] [PDF]

				H. Sugimura, F. C. Nichols, P. Yang, M. S. Allen, S. D. Cassivi, C. Deschamps, B. A. Williams, and P. C. Pairolero Survival After Recurrent Nonsmall-Cell Lung Cancer After Complete Pulmonary Resection Ann. Thorac. Surg., February 1, 2007; 83(2): 409 - 418. [Abstract] [Full Text] [PDF]

				I. Hunt, S. C. Rankin, and L. Lang-Lazdunski Combined lung resection and transdiaphragmatic adrenalectomy in patients with non-small cell lung cancer and homolateral solitary adrenal metastasis. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 194 - 195. [Abstract] [Full Text] [PDF]

				O. Mercier, E. Fadel, M. de Perrot, S. Mussot, F. Stella, A. Chapelier, and P. Dartevelle Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 136 - 140. [Abstract] [Full Text] [PDF]

				V. Patel and J. B. Shrager Which Patients with Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection? Oncologist, May 1, 2005; 10(5): 335 - 344. [Abstract] [Full Text] [PDF]

				R. Kumar, Y. Xiu, J. Q. Yu, A. Takalkar, G. El-Haddad, S. Potenta, J. Kung, H. Zhuang, and A. Alavi 18F-FDG PET in Evaluation of Adrenal Lesions in Patients with Lung Cancer J. Nucl. Med., December 1, 2004; 45(12): 2058 - 2062. [Abstract] [Full Text] [PDF]

				D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al. American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353. [Full Text] [PDF]

				L. Lang-Lazdunski, F. Le Pimpec-Barthes, and M. Riquet Videothoracoscopic splanchnicectomy for intractable pain from adrenal metastasis Ann. Thorac. Surg., April 1, 2002; 73(4): 1290 - 1292. [Abstract] [Full Text] [PDF]

				H. Porte, J. Siat, B. Guibert, F. Lepimpec-Barthes, R. Jancovici, A. Bernard, A. Foucart, and A. Wurtz Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Ann. Thorac. Surg., March 1, 2001; 71(3): 981 - 985. [Abstract] [Full Text] [PDF]

				T. Shibata, Y. Maetani, F. Ametani, K. Itoh, and J. Konishi Percutaneous Ethanol Injection for Treatment of Adrenal Metastasis from Hepatocellular Carcinoma Am. J. Roentgenol., February 1, 2000; 174(2): 333 - 335. [Abstract] [Full Text] [PDF]

				F. G. Pearson Non-small Cell Lung Cancer* : Role of Surgery for Stages I-III Chest, December 1, 1999; 116 (2009): 500S - 503S. [Abstract] [Full Text] [PDF]

				M. de Perrot, M. Licker, J. H. Robert, and A. Spiliopoulos Long-term survival after surgical resections of bronchogenic carcinoma and adrenal metastasis Ann. Thorac. Surg., September 1, 1999; 68(3): 1084 - 1085. [Abstract] [Full Text] [PDF]